FDA panel urges stricter Rezulin warnings

Article Abstract:

An FDA panel ruled that Rezulin should only be used by diabetics in combination therapies and when other therapies have failed. It asked the FDA to require the packaging of the drug to include warnings on the risk of liver failure. The panel also said that the drug's effectiveness in lowering the blood sugar of patients outweigh the risks of liver damage. Rezulin manufacturer Warner-Lambert welcomed the panel's recommendations and said that these reaffirm the fact that the drug's benefits outweigh its risks.

Laws, regulations and rules, Pharmaceutical industry, Product information, United States. Food and Drug Administration, Rezulin (Medication), Warner-Lambert Co. Parke-Davis Div.

---

Fed up at the pharmacy

Article Abstract:

A new trend in the food service industry is the growing number of pharmacy-themed restaurants. An example is the Barmacy in New York City, NY, which is actually a bar but whose drinks are named after famous drugs such as Xanax, Viagra and Librium. Another restaurant belonging to this category is the Pharmacy in England, which sounds like a pharmacy but is actually as restaurant. Nevertheless, it offers beverages whose names are drugs-related such as Anaesthetic Compound, Retarding Agent and Voltarol.

Marketing, Restaurants

---

Similar abstracts:

• Abstracts: PhRMA comments blindside pharmacy: pharmacy leaders charge PhRMA with being 'divisive.'
• Abstracts: Natural pharmacy expert advises: get educated. Will patients hoard meds during Y2K?
• Abstracts: Cold comfort and the Last Judgement. The complete guide to horse riding holidays. Way out of the ordinary

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.